**23andMe PGS Pharmacogenetics reviews: The 23andMe test uses qualitative genotyping to detect 3 variants during the CYP2C19 gene, 2 variants within the DPYD gene and one variant within the SLCO1B1 gene within the genomic DNA of adults from saliva for the objective of reporting and interpreting information about the processing of certain therapeuti